Autres langues Valneva

Actions

Marché Fermé - Euronext Paris Autres places de cotation 17:35:06 06/06/2024			Varia. 5j.	Varia. 1 janv.
3,872 ^EUR	+1,63 %		-3,92 %	-17,97 %

04/06	Pfizer : article sur un vaccin contre Lyme dans The Lancet	CF
04/06	Jamais contents !

Valneva : Announces Availability of Documentation for its Shareholder Meeting and Provides Corporate Update	05/06
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update	05/06
Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June	04/06
Pfizer : article sur un vaccin contre Lyme dans The Lancet	04/06
Borsa di Italia: Mai contenti!	04/06
Bolsa de Madrid: ¡Nunca contentos!	04/06
Valneva : article sur le vaccin contre Lyme dans The Lancet	04/06
Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases	03/06
Borsa di Italia: Facci sognare, Christine	03/06
Bolsa de Madrid: Haznos soñar, Christine	03/06
Valneva : avis positif du CHMP dans le chikungunya	03/06
Valneva's Chikungunya Vaccine Gains Support From EU Regulator Committee	31/05
Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine	31/05
Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine	31/05
EU regulator recommends use of Valneva's chikungunya vaccine	31/05
Valneva Se Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer	22/05
Valneva Names New Chief Scientific Officer	21/05
Valneva : nomination d'un directeur scientifique	21/05
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer	21/05
Actualización de las fuertes variaciones del día: Volkswagen, Valneva, Solutions 30, Delivery Hero, y muchos otros	14/05

Aucun résultat pour cette recherche